ArticleJournal of cheminformatics2017

Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR.

Dilip Narayanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.